UBTF and systemic sclerosis: The anti-NOR90 antibodies, which target a 90 kDa nucleolar protein and can be detected in other autoimmune diseases, are present in approximately 5% of SSc patients, where they mostly associate with the lcSSc subset and have a favorable prognosis [2].